Cargando…
Verification of tomotherapy dose delivery
Seventy-one patient-specific delivery quality assurance (DQA) plans for the Tomotherapy HI-ART II helical tomotherapy system (TomoTherapy, Inc., Madison, WI, USA) were measured using film and ion chamber. The agreement in absolute point dose was 1.19 ± 0.79%, 1.91 ± 1.39%, 2.14 ± 1.3%, 1.3 ± 0.73% a...
Autores principales: | Pelagade, S. M., Paliwal, B. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807687/ https://www.ncbi.nlm.nih.gov/pubmed/20098569 http://dx.doi.org/10.4103/0971-6203.54856 |
Ejemplares similares
-
Performance Characteristics of an Independent Dose Verification Program for Helical Tomotherapy
por: Chang, Isaac C. F., et al.
Publicado: (2017) -
The Impact of the Grid Size on TomoTherapy for Prostate Cancer
por: Kawashima, Motohiro, et al.
Publicado: (2017) -
Dose verification of helical tomotherapy intensity modulated radiation therapy planning using 2D-array ion chambers
por: Xu, S, et al.
Publicado: (2010) -
TomoMQA: Automated analysis program for MVCT quality assurance of helical tomotherapy
por: Han, Min Cheol, et al.
Publicado: (2020) -
Gonadal-sparing total body irradiation with the use of helical tomotherapy for nonmalignant indications
por: Dibs, Khaled, et al.
Publicado: (2021)